Amy Wakeham was appointed Chief Communications and Investor Relations Officer in April 2023, responsible for executive oversight of ResMed’s investor relations, internal and external communications strategy, as well as brand communications and governance for ResMed; as such, she provides communications counsel on a broad range of business issues and initiatives and serves as a key spokesperson for the company. She previously served as vice president of Corporate Communications and Investor Relations since joining ResMed in June 2018.
Amy has over 15 years of experience leading integrated communications teams augmented by 10 years of practical experience in key finance roles in treasury and accounting. Prior to joining ResMed, she served as vice president of Investor Relations & Communications for Integer Holdings Corporation (NYSE: ITGR) and as senior director of Investor Relations & Corporate Communications for Maxwell Technologies (NASDAQ: MXWL). Earlier in her career, she was vice president of Corporate Communications & Investor Relations for Leap Wireless (until its acquisition by AT&T in 2014) and held roles in finance, treasury, and accounting at Leap as well. She started her career in public accounting with Ernst & Young.
Amy also serves on the steering committee of the National Investor Relations Institute’s Senior Roundtable, as a volunteer with Girl Scouts of San Diego since 2018, and as a volunteer fundraiser for the Leukemia and Lymphoma Society since 2012.
Amy holds a Bachelor of Science degree in accounting from Pepperdine University and a Master of Business Administration from the University of California at Irvine.